ÂÜÀòÂÒÂ×

Riccardo Panella is currently working as an Associate Professor at the Center for RNA Medicine, where Riccardo investigates the role of microRNA in metabolic disease and develops new therapeutic strategies. Riccardo is also the Founder and CSO at Resalis Therapeutics Srl, focusing on developing anti-miR compounds for liver diseases, metabolic disorders, and cancer. Riccardo previously worked at the Desert Research Institute and Beth Israel Deaconess Medical Center, conducting research on cancer, metabolism, and genetics. Riccardo holds a PhD in Oncology and Cancer Biology, as well as a Mini-MBA from Harvard Business School.